Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/16880785

Br. J. Cancer 2006 Sep 4 95 5 581-6

Download in:

View as

General Info

PMID
16880785